Key stats
About UBS Global Gender Equality UCITS ETF Accum -A- USD
Home page
Inception date
Dec 19, 2017
Structure
Irish VCIC
Replication method
Physical
Dividend treatment
Capitalizes
Primary advisor
UBS Asset Management (Europe) SA
ISIN
IE00BDR5GV14
The investment objective is to replicate the price and return performance of the Solactive Equileap Global Gender Equality 100 Leaders Net Total Return Index, net of fees.
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Finance
Consumer Non-Durables
Stocks98.89%
Finance30.04%
Consumer Non-Durables11.75%
Health Technology9.20%
Technology Services8.33%
Consumer Services7.09%
Utilities6.40%
Commercial Services5.01%
Transportation4.95%
Communications4.36%
Consumer Durables2.95%
Producer Manufacturing2.84%
Process Industries2.78%
Retail Trade2.16%
Electronic Technology1.02%
Bonds, Cash & Other1.11%
UNIT1.07%
Cash0.04%
Stock breakdown by region
North America50.30%
Europe36.85%
Oceania10.92%
Asia1.93%
Latin America0.00%
Africa0.00%
Middle East0.00%
Top 10 holdings
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows
Frequently Asked Questions
GENE invests in stocks. The fund's major sectors are Finance, with 30.04% stocks, and Consumer Non-Durables, with 11.75% of the basket. The assets are mostly located in the North America region.
GENE top holdings are DoorDash, Inc. Class A and Standard Chartered PLC, occupying 1.67% and 1.51% of the portfolio correspondingly.
GENE assets under management is 82.05 M GBX. It's fallen 28.26% over the last month.
GENE fund flows account for −6.49 B GBX (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
No, GENE doesn't pay dividends to its holders.
GENE shares are issued by UBS Group AG under the brand UBS. The ETF was launched on Dec 19, 2017, and its management style is Passive.
GENE expense ratio is 0.40% meaning you'd have to pay 0.40% of your investment to help manage the fund.
GENE follows the Solactive Equileap Global Gender Equality 100 Leaders Index. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
GENE invests in stocks.
GENE price has fallen by −0.31% over the last month, and its yearly performance shows a 8.56% increase. See more dynamics on GENE price chart.
NAV returns, another gauge of an ETF dynamics, have risen by 1.14% over the last month, showed a 2.37% increase in three-month performance and has increased by 7.34% in a year.
NAV returns, another gauge of an ETF dynamics, have risen by 1.14% over the last month, showed a 2.37% increase in three-month performance and has increased by 7.34% in a year.
GENE trades at a premium (0.03%) meaning the ETF is trading at a higher price than the calculated NAV.